Assure Holdings (IONM) AI Stock Analysis

• Market Cap: $175.64K
• Dividend Yield: N/A
• Average Volume (3M): 1.00K
• Price to Earnings (P/E): ―
• Beta (1Y): -29668.58
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 95
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Care Facilities
• EPS (TTM): -3.15
• Shares Outstanding: 3,674,492
• 10 Day Avg. Volume: 1,741
• 30 Day Avg. Volume: 1,000
• PEG Ratio: >-0.01
• Price to Book (P/B): 12.89
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -8.68
• Enterprise Value/Market Cap: 477.60
• Enterprise Value/Revenue: 23.53
• Enterprise Value/Gross Profit: -68.53
• Enterprise Value/Ebitda: -0.91
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 29 Underperform
• Price Target: ―

Assure Holdings receives a low overall stock score due to significant financial difficulties, including declining revenues and consistent losses. Negative technical indicators and poor valuation metrics further weigh down the stock's prospects. The absence of recent earnings call data and corporate events limits the assessment of potential recovery or strategic shifts.

Assure Holdings Business Overview & Revenue Model

Company Description

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. The company has operations in Arizona, Colorado, Kansas, Louisiana, Michigan, Missouri, Nebraska, Nevada, Pennsylvania, South Carolina, Texas, and Utah, the United States. Assure Holdings Corp. is based in Englewood, Colorado.

How the Company Makes Money

Assure Holdings generates revenue primarily by providing intraoperative neuromonitoring services to hospitals and surgical centers. The company employs technologists who work in the operating room and neurologists who monitor the procedures remotely. Revenue is earned through service fees charged to healthcare facilities and insurance reimbursements for the monitoring services provided. Key factors contributing to its earnings include partnerships with hospitals, surgical centers, and insurance companies to facilitate the delivery and reimbursement of these essential medical services.

Assure Holdings Financial Statement Overview

Summary

Overall, Assure Holdings is facing severe financial challenges, evidenced by declining revenues, consistent losses, negative margins, and a strained balance sheet. The company has a high debt burden relative to its assets and is reliant on external financing to maintain operations. These factors suggest potential risks and uncertainties in the company's financial health and future prospects.

Income Statement

Assure Holdings has experienced a significant decline in revenue over recent years, with the latest annual revenue being just 255,000 compared to 29.2 million in 2021. The gross profit margin is negative due to higher costs than revenue, and net income has consistently been negative, indicating sustained losses. The company also shows negative EBIT and EBITDA margins, highlighting operational challenges and a lack of profitability.

Balance Sheet

The balance sheet reflects financial instability, with shareholders' equity turning negative in the latest period, indicating liabilities exceed assets. The debt-to-equity ratio is not calculable due to negative equity, but the high level of debt relative to total assets suggests significant leverage. The return on equity is negative, further emphasizing the company's struggles to generate returns for shareholders.

Cash Flow

Assure Holdings has faced consistent negative free cash flow, although there was a slight improvement in operating cash flow in 2023 compared to 2022. The operating cash flow to net income ratio suggests that cash outflows from operations exceed net losses, and financing activities have been necessary to sustain operations, indicating reliance on external funding.

Breakdown
TTM	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
78.00K	255.00K	10.98M	29.19M	3.52M	17.73M
	Gross Profit
-1.22M	-2.19M	-4.21M	14.87M	-4.39M	12.77M
	EBIT
-18.09M	-20.08M	-27.82M	-2.13M	-16.20M	2.37M
	EBITDA
-20.68M	-19.82M	-18.19M	-1.39M	-15.19M	2.91M
	Net Income Common Stockholders
-20.52M	-26.08M	-30.11M	-2.76M	-15.04M	2.72M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
45.00K	123.00K	905.00K	4.02M	4.39M	59.00K
	Total Assets
5.28M	7.51M	24.25M	48.41M	33.64M	44.38M
	Total Debt
15.60M	14.80M	14.35M	15.87M	7.64M	6.21M
	Net Debt
15.56M	14.68M	13.45M	11.85M	3.26M	6.16M
	Total Liabilities
23.92M	22.85M	18.78M	19.45M	14.43M	34.49M
	Stockholders Equity
-18.64M	-15.34M	5.46M	28.96M	19.21M	9.89M
Cash Flow		Free Cash Flow
-3.43M	-5.04M	-8.11M	-12.94M	-2.85M	-4.28M
	Operating Cash Flow
-3.43M	-5.04M	-8.03M	-13.37M	-2.53M	-4.23M
	Investing Cash Flow
1.88M	-471.00K	-280.00K	1.00K	-7.50M	465.00K
	Financing Cash Flow
-1.55M	4.73M	5.20M	13.01M	14.36M	2.99M

Assure Holdings Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.05
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IONM, the sentiment is Neutral. The current price of 0.05 is below the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.04, and below the 200-day MA of 2.36, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 49.48 is Neutral, neither overbought nor oversold. The STOCH value of 120.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IONM.

Assure Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	54 Neutral	$5.38B	3.40	-45.06%	3.28%	16.75%	-0.02%
APVO	38 Underperform	$3.27M	―	-1023.93%	―	―	83.04%
RSLS	37 Underperform	$1.82M	―	-120.16%	―	-7.74%	93.25%
IONM	29 Underperform	$175.64K	―	170.06%	―	―	―
WINT	28 Underperform	$2.93M	―	-120.01%	―	―	97.84%
ENTO		$2.81M	―	-33.24%	―	―	―
WORX		$1.84M	―	-30.84%	―	―	―

Assure Holdings Corporate Events

Assure Holdings Settles Merger Disputes with Wellgistics

Assure Holdings Corp. has settled all disputes with Wellgistics Health, Inc., formerly Danam Health, Inc., and Assure Acquisition Corp., related to a previously planned merger. As part of the Settlement Agreement, the associated Convertible Note was cancelled, and it was confirmed that no party owes any termination fees or other amounts, effectively ending the merger discussions and any related obligations.